ENTITY

TRex Bio (TRXB US)

7
Analysis
Health Care • United States
A clinical-stage biopharmaceutical company building on regulatory T cell (Treg) biology
more
Exchange Announcement • 14 Oct 2026 04:56

Current Report (Form 8-K | Period ending 2026-10-13)

Exchange Announcement • 10 Oct 2026 05:22

S-8 | Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Exchange Announcement • 10 Oct 2026 05:03

424B4 | Prospectus

No more filings
x